Question: how do nivolumab and ipilimumab work?
Answer: Nivolumab and ipilimumab target and block two different checkpoints, which increases your body's immune response. In this way, the drugs activate immune cells—unleashing them, in effect—so that they can invade tumors and attack melanoma cells. Ipilimumab blocks a checkpoint molecule called CTLA-4.